Terms definition related to cell-cultured and insect products
Summary
SF 1188 would create new labeling and menu-disclosure requirements for foods made from cell-cultured animal tissue and for products made with insect protein. The bill defines “cell-cultured product” as food derived from animal cells grown in a laboratory, and “insect product” as a food product made by combining processed insects with additives to mimic the texture, flavor, appearance, or characteristics of conventional egg, fish, meat, poultry, or related products.
Under the bill, any cell-cultured product sold at wholesale or retail would have to be labeled in prominent type with “cell-cultured,” “lab-grown,” or another commissioner-approved qualifying term. Insect products would also need a prominent label stating “insect protein” or an approved equivalent, and their ingredient lists would have to identify each insect by both common and scientific name. Restaurants and other food service establishments would be required to clearly and prominently identify cell-cultured products, insect products, and foods containing either on menus or bills of fare.
Impact
The bill would add a new section to Minnesota Statutes chapter 31 and make it unlawful to sell or offer for sale covered products without the required disclosures. It would affect manufacturers, wholesalers, retailers, grocery stores, restaurants, and other food service establishments by imposing product-labeling and menu-labeling obligations for alternative proteins. The commissioner of agriculture would have limited discretion to approve similar qualifying terms or disclaimers, but the core effect is to require explicit consumer notice for these products in the marketplace.
Sentiment
The available record shows no committee transcript or vote history, so there is no documented debate or recorded support/opposition in the materials provided. Based on the bill text alone, the measure appears to reflect a consumer-information approach rather than a ban, with the main policy emphasis on transparency and disclosure. The absence of voting and hearing context makes it difficult to assess broader legislative sentiment beyond the bill’s introduction and referral.
Contention
The likely points of contention are the labeling mandates themselves, especially whether terms like “cell-cultured” or “lab-grown” are neutral, sufficiently clear, or potentially stigmatizing. Food producers and sellers of alternative proteins may object to the added compliance burden, while supporters would likely argue that consumers deserve clear notice about novel protein sources and ingredients. Restaurants and retailers may also be concerned about operational costs and menu/label changes, while the requirement to list both common and scientific insect names could be seen as especially burdensome.
Relating to a prohibition on the offering for sale and the sale of cell-cultured protein for human consumption; providing civil and criminal penalties.